LifeStream Blood Bank

Welcome to LifeStream

AABB Audioconference Schedule

4/23/20 – Novel Approaches for Stem Cell Mobilization

Thursday, April 23, 2020
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 20EL-526 (see program format numbers below under Registration)

  • Educational Track: Technical/Clinical
  • Topic: Cellular Therapies
  • Intended Audience: Hospitals, Hospital Blood Banks, Medical Directors, Nurses, Physicians, Research Scientists, Residents/Fellows, Scientists, Students (MD, MT, SBB), Technologists
  • Teaching Level: Intermediate
  • Director/Moderator: Thomas Spitzer, MD, Director, Cellular Therapy and Transplantation Laboratory, Massachusetts General Hospital, Boston, MA
  • Speaker: Jonathan Hoggatt, PhD, Assistant Professor of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA
Learning Objectives

After participating in this educational activity, participants should be able to:

  • Discuss historical approaches to hematopoietic stem cell mobilization.
  • Describe the benefits and limitations of current stem cell mobilization approaches.
  • Discuss a novel mobilization strategy involving the CXCR2 agonist GROβ and the CXCR4 agonist AMD3100.
Program Description

This program will review the available approaches and the benefits and limitations of each to stem cell mobilization for hematopoietic cell transplantation, and discuss a promising novel, rapid strategy for stem cell mobilization utilizing the CXCR2 agonist GROβ and the CXCR4 agonist AMD3100.


4/29/20 – Repeat Antibody Screens: What is the Appropriate Interval?

Wednesday, April 29, 2020
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 20EL-528 (see program format numbers below under Registration)

  • Educational Track: Technical/Clinical
  • Topic: Transfusion Medicine
  • Intended Audience: Directors, Hospitals, Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Research Scientists, Residents/Fellows, Scientists, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
  • Teaching Level: Intermediate to Advanced
  • Director/Moderator: Geoffrey Wool, MD, PhD, Assistant Professor, Transfusion Medicine Service, University of Chicago, Chicago, IL
  • Speaker: Christopher A. Tormey, MD, Associate Professor of Laboratory Medicine and Lecturer in Molecular Biophysics and Biochemistry, Yale University; Medical Director, Transfusion Medicine Service, Laboratory Medicine, Yale-New Haven Hospital, VA Connecticut Healthcare System; Director, Transfusion Medicine Fellowship, Yale School of Medicine, New Haven, CT
Learning Objectives

After participating in this educational activity, participants should be able to:

  • Describe kinetics of antibody development, including evanescence and anamnestic response.
  • Apply principles of immunoglobulin production to policy development for antibody screen expiration.
  • Identify situations where the extension of antibody screen expiration date could increase patient risk for hemolytic reaction.
Program Description

Antibody screens are generally repeated every three days in recently transfused or pregnant patients, given the risk of new antibody formation. In patients without recent transfusion or pregnancy, the interval between antibody screens can be extended and this is typically convenient for pre-operative patients distant from the hospital. However, the optimal time to extend expiration time in select patient populations is not known. This eCast will also discuss the timing of antibody development and evanescence, as they impact compatibility testing.


6/10/20 -Transfusion Medicine Education to non-TM Physicians & Nurses

Wednesday, June 10, 2020
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 20EL-542 (see program format numbers below under Registration)

  • Educational Track: Quality Education
  • Topic: Transfusion Medicine
  • Intended Audience: Hospitals, Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Perfusionists, Physicians, Residents/Fellows, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
  • Teaching Level: Basic to Intermediate
  • Director/Moderator: April Hord, BB(ASCP)SBB, M.Ed, Immunohematology Reference Laboratory Technical Trainer, American Red Cross – Mid-Atlantic, Richmond, VA
  • Speakers: Natalie Case, MS, MLS(ASCP)CMSBBCM, Technical Supervisor, Virginia Commonwealth University Health System, Richmond, VA; Hind Jaber-Daou, Virginia Commonwealth University Health System, Richmond, VA
Learning Objectives

After participating in this educational activity, participants should be able to:

  • List informational topics provided to help treat patients in respect to their transfusion needs.
  • Discuss the various transfusion medicine educational topics outlined in the program.
  • Apply the concepts discussed in the presentation to everyday practice when dealing with patients and their transfusion medicine needs.
Program Description

This program will highlight Transfusion Medicine topics that would prove helpful for non-transfusion medicine trained doctors and nurses. The program will be presented with viewpoints from transfusion medicine technologists, nurses and doctors discussing what information is most commonly not widely known when dealing with patients who need transfusion or patients with complex antibodies.


6/24/20 – Immunohematology Boot Camp: Kidd/Kell

Wednesday, June 24, 2020
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 20EL-546 (see program format numbers below under Registration)

  • Educational Track: Transfusion Medicine
  • Topic: Transfusion Medicine
  • Intended Audience: Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Residents/Fellows, Students (MD, MT, SBB), Technologists
  • Teaching Level: Intermediate
  • Director/Moderator: Daniela Hermelin, MD, Associate Director of Transfusion Medicine, SSM Saint Louis University Hospital, Saint Louis, MO
  • Speaker: Natalie Phillips, MLS(ASCP)CMSBBCM, Lead Medical Laboratory Scientist, Transfusion Service, Versiti, Milwaukee, WI
Learning Objectives

After participating in this educational activity, participants should be able to:

  • Describe the biochemistry and molecular basis of the Kell and Kidd Blood Group System antigens.
  • Discuss the inheritance and serological expression of common Kell and Kidd antigens, including altered and null phenotypes.
  • Discuss the clinical significance of common Kell and Kidd antibodies.
  • Identify the special characteristics of Jk (a-b-) red cells.
  • Explain why Kidd antibodies are a challenge to detect in routine pre-transfusion testing.
Program Description

The Kell and Kidd Blood Group Antigens are red blood cell glycoproteins that can produce antibodies that are highly clinically significant as they can lead to hemolytic transfusion reactions and hemolytic disease of the fetus and newborn (HDFN). This program will describe the structure, molecular and biochemical significance of Kell and Kidd Blood Group Antigens, focusing on the inheritance and serological expression including altered and null phenotypes. In addition, the program will discuss why these antibodies are a challenge to detect in routine pre-transfusion testing.


7/22/20 – The Transfusion Committee: How to be Effective and Sustaining

Wednesday, July 22, 2020
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 20EL-556 (see program format numbers below under Registration)

  • Educational Track: Technical/Clinical
  • Topic: Transfusion Medicine
  • Intended Audience: Hospitals, Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Perfusionists, Physicians, Resident/Fellow, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers, Other: CMO’s, Pharmacists, IT, Donor Center Representatives
  • Teaching Level: Basic to Intermediate
  • Director/Moderator: Kerry L. O’Brien, MD, Medical Director, Blood Bank, Beth Israel Deaconess Medical Center, Boston, MA
  • Speakers: Jim Gorham, MD, PhD, Medical Director, Blood Bank and Transfusion Services, University of Virginia, Charlottesville, VA; Carolyn Burns, MD, Patient Blood Management Physician Advisor, Louisville, KY
Learning Objectives

After participating in this educational activity, participants should be able to:

  • Describe how to integrate clinical stakeholders into your facility’s Transfusion Committee.
  • Detail how to engage the members of the committee to commit to attending and fully participating in the committee meetings.
  • Detail how to effectively utilize committee members to aid in the ultimate goals of the committee, such as reducing waste or decreasing inappropriate transfusions.
  • Identify how to improve an ineffective transfusion committee.
Program Description

AABB Standards mandate that transfusing facilities have a peer-review program that addresses transfusion practices for all aspects of blood and blood components. To comply, most institutions have created a Transfusion Committee to review ordering practices, adverse events, blood administration policies, wastage and utilization and appropriateness of use. This presentation hopes to describe ways to make your institution’s committee effective and sustainable in the current healthcare climate of never-ending budgetary constraints. Experiences from a health care system and a single institution will be described.


8/12/20 – AABB Nonconformances Case Studies

Wednesday, August 12, 2020
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 20EL-564 (see program format numbers below under Registration)

  • Educational Track: Quality Education
  • Topic: Transfusion Medicine
  • Intended Audience: Directors, Hospitals, Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Perfusionists, Residents/fellows, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
  • Teaching Level: Basic to Intermediate
  • Director/Moderator: April Hord, BB(ASCP)SBB M.Ed, Immunohematology Reference Laboratory Technical Trainer, American Red Cross – Mid-Atlantic, Richmond, VA
  • Speakers: Nancy Shotas, MT(ASCP)BB, CQA(ASQ), Lead Quality Assessor, AABB, Bethesda, MD; Emmett Gourdine, MS, MPA, SAB, MLS (ASCP)SBB, CQM/OE, COA (ASQ), Lead Quality Assessor, AABB, Bethesda, MD

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Identify evidence and standards used in AABB nonconformances.
  • Describe the corrective actions process for resolution of AABB nonconformances.
  • Apply the knowledge learned from the case studies to future AABB assessments.

Program Description

Nonconformances and their corrective actions can be daunting sometimes, from understanding the standard and the evidence to then know what to do to fix the problem and reporting that back to AABB. This program will provide case studies highlighting AABB nonconformances from beginning to end, starting with discovery and documenting evidence; interpreting the standards involved and thru reporting and corrective actions taken.


11/18/20 – Addressing Common Citations from AABB and CAP – 2020 Edition

Wednesday, November 18, 2020
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 20EL-594 (see program format numbers below under Registration)

  • Educational Track: Quality Education
  • Topic: Transfusion Medicine
  • Intended Audience: Directors, Hospitals, Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Physicians, Residents/Fellows, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
  • Teaching Level: Basic
  • Director/Moderator: Isabella Martin, MD, Medical Director of Microbiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
  • Speakers: Anne Chenoweth, MBA, MT(ASCP)CM, CQA(ASQ), Senior Director of Accreditation and Quality, AABB, Bethesda, MD; Lilly Petkovic, MT(ASCP)SBB, Checklist Technical Content Analyst, College of American Pathologists, Northfield, IL

Learning Objectives

After participating in this educational activity, participants should be able to:

  • List common AABB nonconformances in the Transfusion Services, Donor Services, IRL, and Perioperative services.
  • List common CAP checklist deficiencies from the Transfusion Medicine, All Common and Lab General checklists.
  • Expand discussion on selected items to include interpretation of requirements, variations in interpretation and execution of intent.
  • Provide guidance on steps to avoid nonconformances/deficiencies.

Program Description

Lecture to be presented by representatives from AABB and CAP accreditation teams. AABB standards and CAP checklist interpretations that resulted in nonconformances and deficiencies will be highlighted. Speakers will expand discussion on selected items to include interpretations of standards, variations in interpretation and will provide guidance on ways to avoid nonconformance/deficiencies.

Translate »